Flaxseed Consumption on Biochemical and Quality of Life in Type 2 Diabetes

Adult individuals between the ages of 19-65, with a body mass index (BMI) between 20-35 kg/m2, using oral anti-diabetics and not using insulin will be included in the study. Patients with T2DM who agree to participate in the study will be randomly assigned to the intervention or control group using the simple randomization method. Participants will be followed for 12 weeks. Both groups will receive diet as part of T2DM treatment. Subjects in the intervention group will consume 30 g of ground flaxseed per day in addition to their diet. The participants were asked by the researchers through a face-to-face interview technique to determine their demographic characteristics (age, marital status, education level, employment status, income level, etc.), quality of life short form (SF-36) scale, international physical activity questionnaire (IPAQ) and 3-day food consumption record. A survey form questioning consumption records will be applied at the baseline and end of the study. In addition, routinely monitored biochemical parameters of the patients will be recorded from the hospital system at the baseline and end of the study. Anthometric measurements will be taken and recorded by the researcher in accordance with the method. The data obtained will be evaluated in the SPSS package program.

Inclusion criteria

• Diagnosed with T2DM by a physician
• Being between the ages of 19-65
• Having a body mass index (BMI) between 20-35 kg/m2
• Using oral anti-diabetics and not using insulin

Exclusion criteria

• History of gastrointestinal diseases
• High consumption of nuts, flaxseeds or sesame seeds (more than one serving per day)
• Food allergies or intolerances
• Malignancies
• Renal failure, liver, other endocrine or inflammatory disorders
• Use of lipid-lowering drugs
• Smoking and alcohol use
• Being pregnant or lactating